Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M414195-2mg | 2mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $128.90 | |
M414195-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $266.90 | |
M414195-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $860.90 |
CDK9 Selective Inhibitors
Synonyms | MC180295 | 2237942-08-2 | CHEMBL4764481 | (4-amino-2-{[(1S,2S,4R)-bicyclo[2.2.1]heptan-2-yl]amino}-1,3-thiazol-5-yl)(2-nitrophenyl)methanone | [4-amino-2-[[(1S,2S,4R)-2-bicyclo[2.2.1]heptanyl]amino]-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone | DTXSID001115307 | EX-A3 |
---|---|
Specifications & Purity | ≥99% |
Biochemical and Physiological Mechanisms | MC180295 ((rel)-MC180295) is a novel potent and selective CDK9 inhibitor with an IC50 of 5 nM and is at least 22-fold more selective for CDK9 over other CDKs. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Information MC180295 ((rel)-MC180295) is a novel potent and selectiveCDK9inhibitor with an IC50 of 5 nM and is at least 22-fold more selective for CDK9 over other CDKs. Targets CDK9-Cyclin T1 (Cell-free assay); CDK4-Cyclin D (Cell-free assay); CDK1-Cyclin B (Cell-free assay); CDK5-P35 (Cell-free assay); CDK5-P25 (Cell-free assay) 31874,5 nM; 112 nM; 138 nM; 159 nM; 186 nM In vitro MC180295 has broad anti-cancer activity in vitro. In vivo MC180295 shows promising anti-tumoral and immunosensitization activity. Cell Research(from reference) Cell lines:Normal lung fibroblast (IMR90) and cancer cell lines (HCT116, KG-1, HL-60, SW48, MCF7, DU145 and LnCaP) Concentrations:0.1 μM Incubation Time:4 days |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | [4-amino-2-[[(1S,2S,4R)-2-bicyclo[2.2.1]heptanyl]amino]-1,3-thiazol-5-yl]-(2-nitrophenyl)methanone |
---|---|
INCHI | InChI=1S/C17H18N4O3S/c18-16-15(14(22)11-3-1-2-4-13(11)21(23)24)25-17(20-16)19-12-8-9-5-6-10(12)7-9/h1-4,9-10,12H,5-8,18H2,(H,19,20)/t9-,10+,12+/m1/s1 |
InChi Key | JRNXAQINDCOHGS-SCVCMEIPSA-N |
Canonical SMILES | C1CC2CC1CC2NC3=NC(=C(S3)C(=O)C4=CC=CC=C4[N+](=O)[O-])N |
Isomeric SMILES | C1C[C@H]2C[C@@H]1C[C@@H]2NC3=NC(=C(S3)C(=O)C4=CC=CC=C4[N+](=O)[O-])N |
PubChem CID | 137333456 |
Molecular Weight | 358.41 |
Enter Lot Number to search for COA:
Solubility | Solubility (25°C) In vitro DMSO: 72 mg/mL (200.88 mM); Ethanol: 72 mg/mL (200.88 mM); Water: Insoluble; |
---|